ZielBio to Present Interim Findings from its Phase 1/2, Firs

ZielBio to Present Interim Findings from its Phase 1/2, First-in-Human Trial of ZB131 at 2023 ASCO Annual Meeting

/PRNewswire/ -- ZielBio, Inc., a clinical stage biotechnology company discovering new treatments for cancer and other serious diseases, will present the first...

Related Keywords

United States , San Antonio , Texas , American , David Sommerhalder , Prnewswire Zielbio Inc , American Society Of Clinical Oncology , Clinical Oncology , Alan Bash , Zielbio , Nc ,